Amyloid-β at sublethal level impairs BDNF-induced arc expression in cortical neurons

https://doi.org/10.1016/j.neulet.2005.12.057Get rights and content

Abstract

Alzheimer's disease (AD) is characterized by progressive memory loss and cognitive dysfunction that probably due to a deficit in synaptic plasticity. One member of neurotrophins, brain-derived neurotrophic factor (BDNF), is known to be involved in the hippocampal long-term potentiation (LTP), a cellular model for learning and memory. Moreover, activity-regulated cytoskeleton-associated gene (Arc), an immediate early gene, is found to be a downstream effector of the BDNF signaling cascade. Inhibition of Arc protein synthesis impairs both the maintenance of LTP and the consolidation of long-term memory. In addition, the formation of senile plaques is a pathological feature in AD and mainly consists of the deposition of amyloid-β (Aβ), a proteolytic product of amyloid precursor protein. Several studies concerning neurobehavioral performance have suggested that Aβ at sublethal levels interfere with the signaling cascades critical for synaptic plasticity and thus lead to the cognitive impairment in early stage of AD. Whether the BDNF-mediated Arc synthesis is impaired by sublethal Aβ in early AD is still unclear. Therefore, in the present study, primary cultures of neonatal rat cortical neurons were used to evaluate the effect of sublethal Aβ on the BDNF-induced Arc protein expression. Consistent with the literature, Arc, an indicator of synaptic plasticity, was induced by BDNF (25 ng/ml) in both dose- and time-dependent manners. After treating cultures with sublethal Aβ (5 μM), a significant suppression was observed on the level of BDNF-induced Arc protein expression. This result indicates that Aβ at sublethal level impairs the BDNF-mediated signaling in cortical neurons and thus underlies the deficits of synaptic plasticity occurred at the early stage of AD before significant neuronal loss.

Section snippets

Acknowledgment

This study was supported by grants from National Science Council in Taiwan (NSC-94-2320-B-037-019).

References (42)

  • E.M. Blalock et al.

    Gene microarrays in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment

    J. Neurosci.

    (2003)
  • T.V.P. Bliss et al.

    A synaptic model of memory: long-term potentiation in the hippocampus

    Nature

    (1993)
  • C.A. Dickey et al.

    Amyloid suppresses induction of genes critical for memory consolidation in APP + PS1 transgenic mice

    J. Neurochem.

    (2004)
  • C.A. Dickey et al.

    Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein + presenilin-1 transgenic mice

    J. Neurosci.

    (2003)
  • A. Figurov et al.

    Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus

    Nature

    (1996)
  • U. Frey et al.

    Synaptic tagging and long-term potentiation

    Nature

    (1997)
  • J.F. Guzowski et al.

    Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of long-term memory

    J. Neurosci.

    (2000)
  • J.F. Guzowski et al.

    Environment-specific expression of the immediate-early gene Arc in hippocampal neuronal ensembles

    Nat. Neurosci.

    (1999)
  • J. Hardy et al.

    The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

    Science

    (2002)
  • L. Holcomb et al.

    Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

    Nat. Med.

    (1998)
  • A.Y. Hsia et al.

    Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models

    Proc. Natl. Acad. Sci. U.S.A.

    (1999)
  • Cited by (41)

    • Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review

      2021, Ageing Research Reviews
      Citation Excerpt :

      Dysfunction of the PKA/CREB pathway and subsequent genes is strongly implicated in AD etiology and can be disrupted by Aβ-dependent or independent mechanisms (Bartolotti et al., 2016; Rudy, 2020). Aβ peptides are reported to inhibit the expression of Arc and to impair BDNF-TrkB signaling (Echeverria et al., 2007; Wang et al., 2006). Some BDNF polymorphisms increase the risk for AD (Urbina-Varela et al., 2020), or might even increase the susceptibility to depression in AD patients (Borroni et al., 2009), while overexpression of TrkB is found to enhance memory (Rudy, 2020).

    • Rolipram-induced improvement of cognitive function correlates with changes in hippocampal CREB phosphorylation, BDNF and Arc protein levels

      2016, Neuroscience Letters
      Citation Excerpt :

      Our findings suggest that rolipram supplementation of diabetic rats results in a significant increase in hippocampal Arc/Arg3.1 protein levels as well as memory and cognitive ability, an event which appears to be linked to increased BDNF and CREB activity in the hippocampus. In agreement with this, previous studies have indicated that subchronic Rolipram delivery increased the basal rat hippocampal expression and phosphorylation of CREB, as well as the expression of Arc protein [9,22]. In an exogenous BDNF-induced LTP model increased CREB activation and Arc mRNA and protein expression was simultaneously observed [36].

    • BONLAC: A combinatorial proteomic technique to measure stimulus-induced translational profiles in brain slices

      2016, Neuropharmacology
      Citation Excerpt :

      Finally, our comparison of BDNF-induced proteomic changes in slices versus neurons revealed that the majority of the protein candidates altered were strikingly different. Some of the changes in candidate protein abundance suggested by the neuronal culture screen had been reported previously and/or validated, supporting the findings of the BONLAC screen (Liao et al., 2009; Ying et al., 2002; Wang et al., 2006; Okuno et al., 2012). The difference between the proteomic candidates identified in neuronal cultures and those in slices are likely not due to the difference in timeframe (1-h BDNF treatment versus 2-h) as Liao et al. (2007) measured changes after 30 min of BDNF treatment.

    View all citing articles on Scopus
    View full text